Substance use patterns of HVTN phase I clinical trial participants: Enrollment, Risk Reduction Counseling and Retention

BACKGROUND: The primary objectives of HIV Vaccine Trials Network (HVTN) phase 1 preventive HIV vaccine clinical trials are to assess safety and immune response to study products. Participant alcohol and drug use may affect adherence, retention, and risk of HIV infection. Data on the effects of subst...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Vaccine
Hlavní autoři: Andrasik, Michele Peake, Thiam-Diouf, Arame, Metch, Barbara, Sharpe, Cameron, Mulugeta, Robel
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828683/
https://ncbi.nlm.nih.gov/pubmed/29395528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.11.032
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky